Light Mode
$0.0006 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0006, and at the day’s high of $0.0006
-0.00 (-80.00%) / 6M
Momentum, market sentiment, and recent alerts
TTOO reads n/a: price sits below both the 20- and 200-day averages, the 12-month move is -95.0%.
No alerts for TTOO in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
T2 Biosystems, Inc. is a vitro diagnostics company, which engages in the development of detection of sepsis-causing pathogens. It offers T2Dx instrument, T2Bacteria, T2Candida, T2Biothreat panels, and T2MR technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.